Does taking a daily baby aspirin (acetylsalicylic acid) due to In Vitro Fertilization (IVF) transfer in the first 6 weeks of pregnancy affect omega-3 supplementation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Omega-3 Supplementation During Pregnancy with Low-Dose Aspirin

Low-dose aspirin therapy during early pregnancy does not negatively impact omega-3 supplementation, and both can be safely used together during pregnancy. 1

Safety of Combined Use

  • Low-dose aspirin (81-100mg daily) used during IVF and early pregnancy does not contraindicate omega-3 fatty acid supplementation 1
  • Maternal aspirin ingestion is associated with excretion of salicylates into breast milk, but low-dose aspirin (<100mg/day) has not been shown to have significant effects on neonatal platelet function 1
  • For lactating women using low-dose aspirin for vascular indications who wish to breastfeed, guidelines suggest continuing this medication (Grade 2C recommendation) 1

Benefits of Combined Therapy

  • Omega-3 fatty acids are essential nutrients that can only be obtained from diet and are critical for fetal neurodevelopment 2

  • Omega-3 supplementation during pregnancy is associated with:

    • Reduced risk of preterm birth <37 weeks (RR 0.89) 3
    • Significantly reduced risk of early preterm birth <34 weeks (RR 0.58) 3, 4
    • Increased mean gestational age by 1.95 weeks 4
    • Increased mean birth weight by 122.1g 4
  • The combination of low-dose aspirin with omega-3 has been shown to be more effective than aspirin alone in:

    • Increasing fetal weight in cases of intrauterine growth restriction 5
    • Improving uteroplacental blood flow 5

Recommendations for Use

  • For women undergoing IVF who are taking low-dose aspirin, omega-3 supplementation can be safely continued throughout pregnancy 1, 3
  • Low-dose aspirin (50-100 mg/day) is recommended throughout pregnancy for women at risk of preeclampsia 1
  • Omega-3 supplementation should be considered as it has been associated with increased probability of conception (1.51 times higher) 6

Special Considerations

  • If delivery is planned, aspirin should be discontinued one week prior to surgical procedures (including delivery) and restarted 24 hours after surgery when bleeding risk is acceptable 1
  • For women at high risk of preeclampsia, low-dose aspirin should be started in the first trimester 1
  • In cases of high-risk pregnancy, consider continuing low-dose aspirin throughout pregnancy and for six weeks postpartum 1

Dosing Considerations

  • Most studies used omega-3 doses ranging from 600mg to 2.7g daily during pregnancy 3
  • Low-dose aspirin (81-100mg daily) is the standard dose used during pregnancy 1
  • The combination appears safe and may have synergistic benefits for pregnancy outcomes 5

Potential Pitfalls and Caveats

  • Aspirin should be discontinued 1-2 weeks prior to delivery to reduce bleeding risk 1
  • High-dose aspirin (several grams per day) should be avoided as it has been associated with metabolic acidosis in breastfed infants 1
  • While omega-3 supplementation reduces preterm birth risk, it may slightly increase the risk of prolonged gestation >42 weeks (RR 1.61) 3
  • Monitor for any signs of bleeding, though studies show no increased risk of postpartum hemorrhage with low-dose aspirin use 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Omega-3 Fatty Acid supplementation during pregnancy.

Reviews in obstetrics & gynecology, 2008

Research

Omega-3 fatty acid addition during pregnancy.

The Cochrane database of systematic reviews, 2018

Research

Omega-3 fatty acid supplementation and fecundability.

Human reproduction (Oxford, England), 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.